Invacare Corporation (IVC)
Stock Price Chart
Key Info
| Market Cap | 301.45M |
| Revenue (ttm) | 859.56M |
| Net Income (ttm) | -41.85M |
| Shares Out | 34.41M |
| EPS (ttm) | -1.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.05 |
| Dividend Yield | 0.57% |
Stock Quote
| Trading Day | November 25 |
| Last Price | $8.76 |
| Previous Close | $9.11 |
| Change ($) | -0.35 |
| Change (%) | -3.84% |
| Day's Open | 9.04 |
| Day's Range | 8.67 - 9.11 |
| Day's Volume | 138,108 |
| 52-Week Range | 3.90 - 9.97 |
More Stats
| Market Cap | 301.45M |
| Enterprise Value | 537.21M |
| Earnings Date (est) | Feb 11, 2021 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 34.41M |
| Float | 32.78M |
| EPS (basic) | -1.23 |
| EPS (diluted) | -1.24 |
| FCF / Share | -0.34 |
| Dividend | $0.05 |
| Dividend Yield | 0.57% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 4.76M |
| Short Ratio | 19.59 |
| Short % of Float | 14.53% |
| Beta | 1.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 0.92 |
| Revenue | 859.56M |
| Operating Income | -3.69M |
| Net Income | -41.85M |
| Free Cash Flow | -11.83M |
| Net Cash | -235.77M |
| Net Cash / Share | -6.85 |
| Gross Margin | 30.49% |
| Operating Margin | -0.43% |
| Profit Margin | -4.90% |
| FCF Margin | -1.38% |
| ROA | 0.78% |
| ROE | -12.96% |
| ROIC | -1.40% |
Analyst Forecasts
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 928 | 972 | 966 | 1,047 | 1,142 | 1,270 | 1,335 | 1,416 | 1,482 | 1,425 |
| Revenue Growth | -4.56% | 0.61% | -7.73% | -8.3% | -10.06% | -4.82% | -5.74% | -4.49% | 4.06% | - |
| Gross Profit | 262 | 268 | 269 | 284 | 313 | 347 | 367 | 427 | 474 | 472 |
| Operating Income | -10.41 | -18.29 | -40.16 | -22.60 | -7.79 | -58.83 | -40.77 | 8.44 | 20.61 | 87.14 |
| Net Income | -53.33 | -43.92 | -76.54 | -42.86 | -26.19 | -56.07 | 33.05 | 1.83 | -4.11 | 25.34 |
| Shares Outstanding | 33.59 | 33.12 | 32.75 | 32.47 | 32.17 | 32.01 | 31.92 | 31.64 | 31.96 | 32.39 |
| Earnings Per Share | -1.59 | -1.33 | -2.34 | -1.32 | -0.81 | -1.75 | 1.03 | 0.06 | -0.13 | 0.78 |
| EPS Growth | - | - | - | - | - | - | 1616.67% | - | - | - |
| Dividend Per Share | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.03 | 0.06 | 0.04 |
| Dividend Growth | -1.96% | 30.77% | -22% | -1.96% | 0% | -7.27% | 66.67% | -42.11% | 62.86% | - |
| Operating Cash Flow | 2.74 | -46.42 | -25.77 | -56.61 | -5.38 | 8.89 | 10.05 | 62.29 | 99.08 | 122 |
| Capital Expenditures | -10.80 | -6.26 | -14.20 | -10.11 | 15.60 | -9.81 | -13.27 | -19.93 | -22.10 | -17.32 |
| Free Cash Flow | -8.06 | -52.68 | -39.97 | -66.72 | 10.22 | -0.91 | -3.22 | 42.36 | 76.98 | 105 |
| Cash & Equivalents | 80.06 | 117 | 177 | 124 | 60.06 | 38.93 | 29.79 | 38.79 | 34.92 | 48.46 |
| Total Debt | 267 | 256 | 243 | 161 | 47.12 | 20.33 | 45.29 | 235 | 265 | 246 |
| Net Cash / Debt | -187 | -139 | -66.92 | -37.12 | 12.94 | 18.60 | -15.50 | -196 | -231 | -198 |
| Assets | 852 | 886 | 1,066 | 904 | 838 | 964 | 1,096 | 1,262 | 1,281 | 1,280 |
| Liabilities | 544 | 527 | 643 | 481 | 375 | 398 | 426 | 641 | 655 | 628 |
| Book Value | 309 | 359 | 423 | 422 | 463 | 565 | 671 | 621 | 627 | 652 |
Company Profile
Company Details
| Full Name | Invacare Corporation |
| Country | United States |
| Employees | 3,900 |
| CEO | Matthew E. Monaghan |
Stock Information
| Ticker Symbol | IVC |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NYSE: IVC |
Description
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.